Carl Zeiss | Primamed

PRIMAMED TECHNOLOGIES

X

CARL ZEISS MEDICAL

Get to know Carl Zeiss Medical

The Medical Technology segment of ZEISS offers complete solutions to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions.

With a special focus on ophthalmology, ophthalmic surgery and visualization systems in the field of microsurgery, the company supports healthcare professionals in setting new standards of care with proven medical technology and broad application competence based on cutting-edge innovations. ZEISS also offers visualization solutions for dental treatment and gynecology.

Visit their official website

Life-saving innovations. Take a look at their medical solutions.

The Gradian ICV is an all-in-one ventilator for intensive and critical care, as well as transport and intermediate care.

Versatile Use: With extensive modes and monitoring parameters, in-built turbine, battery backup, and compact form factor, the ICV is easy to use in any location within a hospital, or for transport within or outside the facility.

Advanced Ventilation Modes: The ICV is designed to deliver care to infant, pediatric, and adult patients in any setting. It comes standard with a range of invasive and non-invasive ventilation modes to fit the clinical need, as well as optional modes including high flow oxygen therapy.

Sophisticated Monitoring: Combining extensive monitoring parameters and respiratory diagnostics with dedicated display pages, the ICV can measure, display, store, and export the information needed for precise, high-quality care.

Fully Portable: The ICV’s trolley is designed to easily hold or move the ventilator and accessories, including oxygen cylinder bracket, humidifier, and circuit support arm.

Smart CPR Mode: The innovative CPR mode gives step-by-step audible and visual instructions for performing CPR and breathing as per AHA and ERC’s latest guidelines.

Download its technical specifications

The Prima anesthesia machine is a high specification anesthetic machine providing the ideal solution for today’s busy operating room.

Versatile Use: With extensive modes and monitoring parameters, in-built turbine, battery backup, and compact form factor, the ICV is easy to use in any location within a hospital, or for transport within or outside the facility.

Broad Patient Support: Suitable for adult, pediatric and neonatal patient profiles. Eight ventilation modes are available (VCV, PCV, PRVC, SPONT/PSV, SIMV-V, SIMV-P, SIMV-PRVC, and Manual) with PEEP available in all modes except Manual.

Enhanced Monitoring: 10.4” TFT color touchscreen ventilator display with navigator wheel and audio/visual indicators. Choice of up to 10 waveform and respiratory loop displays. Optional mainstream anesthetic gas and sidestream CO2 and SpO2 monitoring.

Robust Gas Management: Cylinder yokes and pipeline connections, with integrated mechanical anti-hypoxic device. Automatic ventilator drive gas switching between air or oxygen. Absorber with integrated heater and bypass, allowing for mid-ventilation soda lime replacement. Active AGSS for disposal of waste gas.

Additional Accessories: Patient cable management arm to reduce clutter, oxygen therapy outlet for recovery and safety, and optional suction controller kit to keep airways clear.

Download its technical specifications

Designed to address oxygen insecurity across all levels of the health system, the Gradian K-O2 is an independent oxygen generator that delivers uninterrupted oxygen therapy for up to 10 patients at once.

Versatile Use: With extensive modes and monitoring parameters, in-built turbine, battery backup, and compact form factor, the ICV is easy to use in any location within a hospital, or for transport within or outside the facility.

Multi-Patient Therapy: Integrated flow management and distribution for streamlined measurement and control of multiple patient outlets simultaneously, with total flow rate up to 20 LPM.

User-Friendly Interface: Easy-to-read display provides critical information at a glance, including oxygen purity and output flow.

Works Amidst Power Outages: Integrated battery backup provides at least 30 minutes of run time to cover short power outages without interrupting therapy. Standard high-pressure cylinders can also be used in the event of longer outages, with up to 6 hours of battery-enabled monitoring on the K-O2’s interface.

Designed to Last: Built specifically to work in challenging environments with high heat, humidity, dust, and unstable power, the K-O2 is designed with protection against natural elements that take other machines offline.

Download its technical specifications

The Gradian UAM (Universal Anaesthesia Machine) is an innovative anesthesia machine designed to continue working without electricity and medical oxygen.

Versatile Use: With extensive modes and monitoring parameters, in-built turbine, battery backup, and compact form factor, the ICV is easy to use in any location within a hospital, or for transport within or outside the facility.

Dual Low-Resistance Vaporizers: Two-station back bar for low-resistance vaporizers that accurately deliver a calibrated flow of halothane, isoflurane, or sevoflurane with or without a compressed gas source.

Integrated Oxygen Concentrator: Built-in oxygen concentrator that produces up to 10 liters per minute of up to 95 percent oxygen; room air cleaned with dual filtration system.

Oxygen Monitor: Oxygen monitor with settable high- and low-purity alarms displays inspired oxygen content and lasts up to 18 months on battery back-up.

Anesthesia Ventilator: Fully automatic, electrically-driven ventilator with 6-hour rechargeable battery back-up, no drive gas needed.

Patient Vital Signs Monitor: Real-time monitoring of pulse oximetry, ECG, blood pressure, and temperature with 6 hours of battery backup operation.

Universal Bellows: Manual bellows that ensures safe, assisted respiration for adults and children without requiring a high-pressure gas source.

Download its technical specifications

We are committed - alongside other stakeholders in the health sector - to reduce, and ultimately do away with, the need for our loved ones to seek “advanced” medical treatments overseas. They deserve to undergo such procedures in a familiar #environment and more importantly surrounded by their family & friends.

To get one step closer to that goal, we are excited to announce our partnership with ZEISS Medical Technology 🇩🇪, an internationally leading #technology enterprise operating in the fields of optics and optoelectronics - Primamed Technologies Ltd is now their exclusive representative in Rwanda 🇷🇼.

Thanks to this strategic partnership with ZEISS, we will benefit & learn from their technical know-how of 170+ years, equip & train health professionals in Rwanda & the region 🌍 on the latest ZEISS medical solutions (+ innovations💡). However, we are even more excited by the improvement of the patient experience and the fact that their family will be more confident in the outcome.

We cannot wait to see the amazing milestones we will reach with ZEISS. We are striving for "greater efficiency, safety, more patients that can be accommodated, and better results".

📸: Zeiss.

Prof. Dr. Dr. h.c. Frederik Wenz

Chief Medical Officer, CEO of the Medical Center

University of Freiburg

[...] Let’s talk about cancer treatment – what developments do you see in this area that are beneficial to patients?

When it comes to cancer treatment, we will start to see more and more technical devices in use, including robotic assistants for surgery. We will also increase the use of data-driven medicine, which is an area where we can still do a lot. Right now we are basically blind to what happens to the patient before and after the hospital stay, yet there is a lot of data out there on the patient's behavior – including parameters relevant to their condition.

When the patient leaves the hospital, we talk about their outcome measurements. This is where we have to change our approach, especially when it comes to cancer medicine. Sometimes we see a patient on a fixed schedule – every six weeks, or every three months – and we are blind to what happens between these visits. The fact is that some of these patients would need to come more often, and some would need to come less often.

With monitoring devices and sensor systems, we can move from this one-size-fits-all follow-up approach to an adaptive one. Then the patient who needs to see a physician can do so, and patients who don't need treatment do not need to come for an in-person visit.

This is the future of cancer treatment, where digital and other technological developments are used to improve outcomes.